drugset / Press release
MacroGenics to Present Phase 1 Data on Flotetuzumab, a CD123 x CD3 DART® Molecule, at 59th Annual ASH Meeting
2017-11-01 · MacroGenics · original macrogenics.com ↗
MacroGenics to Present Phase 1 Data on Flotetuzumab, a CD123 x CD3 DART® Molecule, at 59th Annual ASH Meeting 11.7 KB
The release as fetched from its publisher. macrogenics.com ↗